Benitec Biopharma Limited

Press Releases

2014-December-16	Benitec Appoints Vice-President Manufacturing (in PDF)
2014-December-10	Benitec's Lung Cancer Collaborators Discover Mechanism of Drug Resistance (in PDF)
2014-November-25	Benitec Files Statement of Appeal to Graham Patent in Europe (in PDF)
2014-November-21	CEO and Managing Director Address to Shareholders (in PDF)
2014-November-13	Results of the Annual General Meeting Held on Thursday 13 November 2014 (in PDF)
2014-November-13	CEO and Managing Director Address to Shareholders Following the 2014 AGM (in PDF)
2014-November-13	Chairman's Address at the Annual General Meeting Held on Thursday 13 November 2014 (in PDF)
2014-November-13	Benitec Announces Second Patient Dosed in the TT-034 Phase I/IIA Clinical Trial (in PDF)
2014-November-3	Benitec Executes License Agreement with Circuit Therapeutics for Pain; Provides TT-034 Trial Commentary (in PDF)
2014-October-31	Shareholder Information Sessions and Webcast (in PDF)
2014-October-30	HCV TT-034 Trial - Update on Progress (in PDF)
2014-October-21	Benitec to Present at ASX Spotlight Asia Investor Conference in Singapore and Hong Kong (in PDF)
2014-October-8	Benitec CEO Presents at Bio-Investor Forum - San Francisco (in PDF)
2014-October-8	TT-034 HCV Trial Update (in PDF)
2014-September-22	Benitec Appeals Graham Patent Revocation in Europe (in PDF)
2014-August-29	HCV Trial Update (in PDF)
2014-August-5	Investor Presentation (in PDF)
2014-July-21	HCV Trial Update (in PDF)
2014-July-18	Bioshares Clinical Trials Presentation (in PDF)
2014-July-11	Attachment to Guidance on Trials Announcement (in PDF)
2014-July-11	Guidance on Clinical Trial Updates (in PDF)
2014-July-1	Unmarkeatble Parcels (in PDF)
2014-June-26	Calimmune Trial Advances (in PDF)
2014-June-19	Director Resignation (in PDF)
2014-June-11	Non Deal Roadshow Presentation (in PDF)
2014-June-6	Federal R&D Grant Received (in PDF)
2014-June-2	US ADR Program Launched (in PDF)
2014-May-30	US ADR to be Established (in PDF)
2014-May-29	Hepatitis C Patient Dosing Commenced (in PDF)
2014-May-23	European Patents Update (in PDF)
2014-May-20	Benitec CEO Presentation at European Biotech Conference (in PDF)
2014-May-12	Update on Hepatitis C Trial (in PDF)
2014-April-30	Astra-Zeneca Presentation (in PDF)
2014-April-15	AUD 31.5 Million Placement Completed (in PDF)
2014-April-10	Results of Meeting (in PDF)
2014-April-10	Chairman's Address to Shareholders (in PDF)
2014-March-17	Craig Lewis Appointed Chief Medical Adviser (in PDF)
2014-March-14	Benitec Roadshow Investor Presentation (in PDF)
2014-March-13	HCV Patient Dosing Timing (in PDF)
2014-March-12	Becoming a Substantial Holder (in PDF)
2014-February-28	First Stage of Placement Raises AUD15.7 Million (in PDF)
2014-February-27	Interim Report for the Half Year Ended December 31, 2013 (in PDF)
2014-February-26	Dr Peter French Discusses A$31.5 Million Placement (in PDF)
2014-February-24	Benitec Raises up to AUD31.5 Million (in PDF)
2014-February-18	University of Westminster Role in TT-034 (in PDF)
2014-February-7	Nature Publication (in PDF)
2014-January-14	Hepatitis C Trial to Proceed (in PDF)
2014-January-6	IND Update (in PDF)
2015	2015 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases